Silexion Therapeutics Corp

Research Silexion Therapeutics Corp (SLXN) on Bullrun: market cap USD 1.08M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSLXN
• ExchangeNASDAQ
• CountryIsrael
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.08M
• Financial periodFY2025
• Net income-USD 11.91M
• Free cash flow-USD 10.83M

Valuation Snapshot

latest market cap is USD 1.08M.

About Silexion Therapeutics Corp

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer;

Frequently asked questions

What is Silexion Therapeutics Corp's market cap?

Silexion Therapeutics Corp's market capitalization is USD 1.08M.

What does Silexion Therapeutics Corp do?

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform.